Showing results (131-140 of 301) with videos related to

Sort By:
Pageof 31
Molecular Immunology|July 4, 2006
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximabJosette Carnahan, Rhona Stein, Zhengxing Qu, et al.
International Journal of Clinical and Experimental Pathology|November 15, 2013
Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinomaSabrina C Sopha, Purva Gopal, Nipun B Merchant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2017
Synthetic Lethality Exploitation by an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2-wild-type Triple-Negative Breast CancerThomas M Cardillo, Robert M Sharkey, Diane L Rossi, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograftRosalyn D Blumenthal, Lou Osorio, Marianne K Hayes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68GaHabibe Karacay, Robert M Sharkey, William J McBride, et al.
Blood|June 18, 2011
Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancersEdmund A Rossi, Diane L Rossi, Thomas M Cardillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an updateRobert M Sharkey, Habibe Karacay, William J McBride, et al.
Pageof 31